Provexis gets US patent on tomato bioactive

By Dominique Patton

- Last updated on GMT

Related tags: Blood

UK-based Provexis has gained patent protection in the US for its
tomato bioactive that improves circulation, allowing it to target
the significant American heart health market.

The company is launching the first functional food using its Fruitflow technology in the UK in January.

The Sirco fruit juice drink will carry the claim that it 'helps to maintain a healthy heart and benefits the circulation'. It will be positioned as heart healthy juice, an emerging category in the functional food market.

But the firm is keen to tap into the US market for heart healthy foods, which it says is expected to reach US$34 billion in sales by 2010.

Its tomato extract has been proven in human trials to inhibit blood platelet aggregation and thereby reduce the risk of thrombosis, a primary cause of heart attack and stroke.

Sirco will be differentiated from cholesterol-lowering foods already available on the European market as its benefit is derived from blood thinning and is said to have an effect from the first serving.

The technology gained patent protection in Europe in July 2003, and in Australia in August 2004. Provexis is also expecting to get patents in Japan, Mexico and Canada in the near future.

However Dr Stephen Franklin, chief executive officer of Provexis, noted that it now has patent protection in its two largest target markets, the United States and Europe.

"We can start to make significant in-roads into the US functional food market,"​ he said.

Related topics: Polyphenols, Cardiovascular health

Related news

Show more

Related products

show more

KaraHeart™ Showed Results in Just 30 Days

KaraHeart™ Showed Results in Just 30 Days

Karallief® Inc | 30-Jun-2022 | Data Sheet

After extensive R&D, scientists at Karallief® developed KaraHeart™ – a patent-pending and clinically tested vegan herbal blend that effectively manages...

Related suppliers

Follow us


View more